[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Developmental Disabilities & Disorders |
Developmental Disabilities |
Clinical Trial: Early Phase II Trials for Cocaine Medication Development - 1
This study is no longer recruiting patients.
Purpose
The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Substance-Related Disorders | Drug: Risperidone | Phase II |
MedlinePlus related topics: Cocaine Abuse; Drug Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Early Phase II Trials for Cocaine Medication Development
Expected Total Enrollment: 25
Study start: June 1994
Eligibility
Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Both
Criteria
Location Information
New York
Research Foundation for Mental Hygiene, New York, New York, 10032, United States
Edward Nunes, M.D., Principal Investigator, Research Foundation for Mental Hygiene
More Information
Record last reviewed: December 2002
Last Updated: March 17, 2005
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000317
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Accommodations for People with Mental Retardation (Job Accommodation Network)
- Adopting Children with Developmental Disabilities (National Adoption Information Clearinghouse, ACYF, ACF, HHS)

Not Signed In -


